Anthony E. Lang
Toronto Western Hospital
University of Toronto
Canada
Name/email consistency: high
- When and how should treatment be started in Parkinson disease? Lang, A.E. Neurology (2009)
- The progression of Parkinson disease: a hypothesis. Lang, A.E. Neurology (2007)
- Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Lang, A.E., Gill, S., Patel, N.K., Lozano, A., Nutt, J.G., Penn, R., Brooks, D.J., Hotton, G., Moro, E., Heywood, P., Brodsky, M.A., Burchiel, K., Kelly, P., Dalvi, A., Scott, B., Stacy, M., Turner, D., Wooten, V.G., Elias, W.J., Laws, E.R., Dhawan, V., Stoessl, A.J., Matcham, J., Coffey, R.J., Traub, M. Ann. Neurol. (2006)
- Deep brain stimulation: preoperative issues. Lang, A.E., Houeto, J.L., Krack, P., Kubu, C., Lyons, K.E., Moro, E., Ondo, W., Pahwa, R., Poewe, W., Tröster, A.I., Uitti, R., Voon, V. Mov. Disord. (2006)
- Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lang, A.E., Obeso, J.A. Lancet. Neurol (2004)
- Corticobasal degeneration: selected developments. Lang, A.E. Mov. Disord. (2003)
- Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Lang, A.E., Widner, H. Mov. Disord. (2002)